Navigation Links
SphygmoCor Px Central Blood Pressure Assessment and Management System

ProductsSphygmoCor Px Central Blood Pressure Assessment and Management System
Company AtCor Medical Pty Ltd.
Item SphygmoCor Px Central Blood Pressure Assessment and Management System
Features The SphygmoCor Px Central Blood Pressure Assessment and Management System has transformed cardiovascular evaluation, enhancing patient assessment and management by providing the following information:
  • Evaluation of systemic arterial stiffness (Aortic Augmentation Index) and its clinical impact on the heart in increasing patient risk of heart failure, stroke and myocardial ischaemia.
  • Augmentation pressure, which drives left ventricular load (afterload) - a key parameter affecting risk of LV hypertrophy.
  • Central Pulse pressure in the ascending aorta (driving cerebral blood flow) giving the true pressure, and hence the risk of stroke.
  • Central systolic pressure, often markedly different from the cuff value.
  • Ejection duration a parameter for distinguishing primarily systolic from primarily diastolic dysfunction, and for managing the efficacy of heart failure therapy.
  • Diastolic pressure-time index (DPTI), a key determinant of coronary blood supply.
  • Systolic pressure-time index (SPTI), a measure of myocardial oxygen demand.
  • Subendocardial Viability Ratio the relationship of DPTI and SPTI, providing a powerful index for risk stratification for myocardial ischaemia.
Description The SphygmoCor Px Central Blood Pressure Assessment and Management System provides a quick and non-invasive method of obtaining central blood pressure and other key cardiovascular data, and is intended to enhance the treatment and management of patients.

Using a validated generalized transfer function, the system derives the ascending aortic blood pressure waveform from the radial arterial pressure waveform. SphygmoCor then analyzes the central aortic waveform to central pressures and other provide key indices of arterial stiffness and cardiovascular risk. These indices include aortic augmentation pressure, aortic augmentation index, ejection duration, and Buckberg Index (subendocardial viability ratio). Data are reported against age- and gender-specific reference normals.

Info AtCor Medical Pty Ltd.
Customer Service: (630) 799-8217
Web site: http://www.atcormedical.com/

Related medicine products :

1. SphygmoCor Vx Central Blood Pressure/Pulse Wave Velocity System
2. SphygmoCor Mx Central Blood Pressure Monitoring System
3. SphygmoCor Px Pulse Wave Analysis System test
4. Innotrac Aio! Central
5. Endoalpha Centralized O.R. Control System
6. Centralized Holter Analysis
7. S/5 iCentral
8. Acuity LT Central Station
9. Mobile Acuity LT™ Central Station
10. Acuity® Central Station
11. Oxinet III Central Station Network
... The Stryker Threaded Dilator ... yet another choice for ... Dilators provide compaction reaming ... compaction of bone within ...
... Conquest Suture Retrievers are ... pierce through soft tissue ... the tissue to create ... Retrievers are front opening ...
... Scissor is ideal for excising soft tissue more ... the joint. The serrated edge on the straight ... hold tissue within the jaws for more efficient ... jaw curvatures, are the perfect tools for ACL ...
... Instrument program offers state-of-the-art quality in an ... strength and durability. Low profile cutting tips ... spaces. Series I instruments are available in ... and angle required for large and small ...
Medicine Products:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... , ... Leading pediatric oncology experts at Children’s National Health System ... of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy ... health literacy software tool, and the Cancer Patient Education Network (CPEN), an independent ... today announce a new strategic alliance. , As CPEN’s strategic partner, HLI ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... SEOUL, South Korea , Oct. 4, 2017 /PRNewswire/ ... launched its next-generation CPR training aide "cprCUBE" on Kickstarter. ... of chest compression during cardiac arrests with better efficiency ... patient-mannequins. It also offers real-time feedback on efficacy of ... The crowdfunding campaign has a goal to raise ...
(Date:10/2/2017)... Lilly and Company (NYSE: LLY ) will ... 2017 on Tuesday, October 24, 2017. Lilly will also ... investment community and media to further detail the company,s ... at 9 a.m. Eastern time. Investors, media and the ... conference call through a link that will be posted ...
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
Breaking Medicine Technology: